iodoantipyrine has been researched along with piperidines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, KM; Chaplin, DJ; Poole, BA; Prise, VE; Tozer, GM | 1 |
| Hurn, PD; Murphy, SJ; Rossberg, MI; Traystman, RJ | 1 |
2 other study(ies) available for iodoantipyrine and piperidines
| Article | Year |
|---|---|
Modification of blood flow in the HSN tumour and normal tissues of the rat by the endothelin ET(B) receptor agonist, IRL 1620.
Topics: Analysis of Variance; Animals; Antipyrine; Blood Pressure; Endothelins; Fibrosarcoma; Heart Rate; Oligopeptides; Peptide Fragments; Piperidines; Rats; Rats, Inbred Strains; Receptors, Endothelin; Reference Values; Regional Blood Flow; Vascular Resistance | 1999 |
LY353381.HCl, a selective estrogen receptor modulator, and experimental stroke.
Topics: Animals; Antipyrine; Autoradiography; Brain Ischemia; Carbon Radioisotopes; Cerebral Infarction; Cerebrovascular Circulation; Disease Models, Animal; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Ovariectomy; Piperidines; Rats; Rats, Wistar; Receptors, Estrogen; Thiophenes | 2000 |